I don't think we should be investigating the investigators. I think that's an effort on the part of Trump to deflect attention from the problems that his campaign had.

Trump has been very, very provocative towards Iran. He's trying to egg them on.

I think that we have got to do everything that we can to see that we do not get involved in a war in Iran.

We have picked sides and we have gone with the dictatorship and the brutal regime in Saudi Arabia.

No war with Iran. This would be an unmitigated disaster. We must stop Trump and his national security adviser John Bolton, someone who likes endless wars.

What we need to do is to figure out a way that we develop a trade policy, which is fair for American workers.

This week, the Congressional PFAS Task Force, including Representatives Kildee, Tonko, and Fitzpatrick, joined me in my district to address clean water and to address PFAS water contamination. I thank them for joining me. We visited Naval…

I thank the gentleman for yielding. Mr. Chairman, if we want to level with the American people, let's acknowledge something: We have a difference of opinion on healthcare. When we passed the Affordable Care Act, it provided, for the first…

All of us have a concern about a formulary. Is that going to restrict patient access?

the pharmaceutical industry creates life-saving and -extending drugs and pain-relieving drugs. That is a good thing. You are killing us with the price and that is on both sides--both sides--and we are trying to get to the bottom of this.

There ought to be transparency--transparency on the rebates and, I think, transparency on how much is really spent on R&D.

I want to thank the panel, and I want to thank you, Madam Chair, and I will yield back the 30 seconds I have.

It cost taxpayers $500 million--500 million bucks.

It really is bizarre what happens.

How essential are they, and how can we provide them?

It is very dispiriting that we are not making the progress on energy efficiency that both sides know is really good.

I endorse everything that my colleague, Mr. Griffith, said, and appreciate you being willing to work with him.

However, as newer and more specialized medicines come to market, these drugs typically have much higher prices that are too often just simply unaffordable.